Molecular profiles of benign and (pre)malignant endometrial lesions-Reference-Cited by-同舟云学术

Molecular profiles of benign and (pre)malignant endometrial lesions

Published:2017-01-25 Issue:3 Volume:38 Page:329-335
ISSN:0143-3334
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

van der Putten Louis J.M.,van Hoof Renée,Tops Bastiaan B.J.,Snijders Marc P.L.M.,van den Berg-van Erp Saskia H.,van der Wurff Anneke A.M.,Bulten Johan,Pijnenborg Johanna M.A.,Massuger Leon F.A.G.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/38/3/329/17295293/bgx008.pdf

Reference51 articles.

1. Cancer of the corpus uteri;Int. J. Gynaecol. Obstet,2015

2. Molecular pathology of endometrial carcinoma;Histopathology,2013

3. Endometrial carcinoma: molecular alterations involved in tumor development and progression;Oncogene,2013

4. Use of mutation profiles to refine the classification of endometrial carcinomas;J. Pathol,2012

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient;Molecular Case Studies;2023-10-17

2. Diagnostic Potential of Endometrial Cancer DNA from Pipelle, Pap-Brush, and Swab Sampling;Cancers;2023-07-06

3. Yield of annual endometrial cancer surveillance in women with PTEN Hamartoma Tumor Syndrome;European Journal of Medical Genetics;2023-07

4. MOLECULAR MECHANISMS OF RESISTANCE OF ENDOMETRIAL HYPERPLASIA TO PROGESTAGEN THERAPY;Grail of Science;2023-03-31

5. Histopathological and molecular findings in 98 cases of endometrial carcinoma: MMR, p53 and next generation sequencing;Pathology - Research and Practice;2023-01